Literature DB >> 7223720

Ameloblastoma of the maxilla with distant metastases and hypercalcemia.

G Madiedo, H Choi, J G Kleinman.   

Abstract

A case of metastatic ameloblastoma of the maxilla with secondary hypercalcemia in a 54-year-old man is presented. After treatment with surgery, chemotherapy, and radiotherapy, the patient was found to have multiple metastases and severe hypercalcemia associated with high levels of parathormone-like substance in the peripheral blood. At autopsy he was found to have widespread metastases and nephrocalcinosis.

Entities:  

Mesh：

Year:  1981        PMID： 7223720     DOI： 10.1093/ajcp/75.4.585

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN： 0002-9173            Impact factor:   2.493


  6 in total

1.  Ameloblastic carcinoma.

Authors:  Hari Ram; Shadab Mohammad; Nuzhat Husain; Prem Narayan Gupta
Journal:  J Maxillofac Oral Surg       Date:  2011-03-17

2.  Overwhelming hypercalcaemia in mandibular ameloblastoma.

Authors:  Tom Edward Ngo Lo; Cesar Vincent Villafuerte; Laura Trajano Acampado
Journal:  BMJ Case Rep       Date:  2014-10-17

Review 3.  New classification of maxillary ameloblastic carcinoma based on an evidence-based literature review over the last 60 years.

Authors:  Astrid L D Kruse; Roger A Zwahlen; Klaus W Grätz
Journal:  Head Neck Oncol       Date:  2009-08-12

4.  Primary ameloblastic carcinoma of the maxilla: A case report and literature review.

Authors:  Narikazu Uzawa; Miho Suzuki; Chika Miura; Nobuyoshi Tomomatsu; Toshiyuki Izumo; Kiyoshi Harada
Journal:  Oncol Lett       Date:  2014-10-31       Impact factor: 2.967

5.  A case of recurrent metastatic ameloblastoma and hypercalcaemia successfully treated with carboplatin and paclitaxel: long survival and prolonged stable disease.

Authors:  Af Ghiam; A Al Zahrani; R Feld
Journal:  Ecancermedicalscience       Date:  2013-06-04

6.  Hypercalcemia caused by metastatic adamantinoma: response to radiotherapy.

Authors:  J A Lyons; G T Budd; R L Crownover
Journal:  Sarcoma       Date:  1999
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.